학술논문
P.07.36 REAL-WORLD EVIDENCE OF VEDOLIZUMAB THERAPY IN ULCERATIVE COLITIS AND CROHN'S DISEASE PATIENTS: FECAL CALPROTECTIN A VALID BIOMARKER OF MUCOSAL INFLAMMATION
Document Type
Abstract
Author
Source
In Digestive and Liver Disease 25 March 2019 51 Supplement 2:e239-e239
Subject
Language
ISSN
1590-8658